Algernon Health Inc.
AGN
CNSX
| 11/30/2025 | 08/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 59.86% | -34.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 61.83% | -35.32% | |||
| Operating Income | -61.83% | 35.32% | |||
| Income Before Tax | -54.15% | 33.12% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -54.15% | 33.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -54.15% | 33.12% | |||
| EBIT | -61.83% | 35.32% | |||
| EBITDA | -68.90% | 40.86% | |||
| EPS Basic | -51.85% | 43.36% | |||
| Normalized Basic EPS | -50.98% | 42.70% | |||
| EPS Diluted | -51.85% | 43.36% | |||
| Normalized Diluted EPS | -50.98% | 42.70% | |||
| Average Basic Shares Outstanding | 1.56% | 18.08% | |||
| Average Diluted Shares Outstanding | 1.56% | 18.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||